Stay updated with breaking news from Philippe Devillier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The French EfficAPSI study confirmed that sublingual liquid immunotherapy or "desensitization" reduces the risks for asthma onset and the worsening of asthma in patients with allergic rhinitis.
Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced positive data from its EfficAPSI real-world study. Presented at the 2022 European Academy